Location History:
- San Antonio, TX (US) (2010 - 2020)
- Shavano Park, TX (US) (2018 - 2021)
Company Filing History:
Years Active: 2010-2021
Title: Michael Richard Girouard: Innovator in Seizure Detection Technologies
Introduction
Michael Richard Girouard is an inventive mind residing in San Antonio, TX, renowned for his significant contributions to the field of medical technology. With a remarkable portfolio of 24 patents, Girouard has established himself as a key player in developing solutions for seizure detection and characterization.
Latest Patents
Among his latest inventions are two groundbreaking patents that focus on monitoring and analyzing seizure activity. The first patent, titled "Method and apparatus for detecting and classifying seizure activity," proposes a comprehensive method for monitoring a patient by collecting electromyography signals. This process involves analyzing the signals through wavelet analysis and utilizing a neural network trained specifically for detecting seizure activity. The second patent, "Systems and methods for characterization of seizures," encompasses techniques to detect and characterize seizures or seizure-related events by determining the magnitude and scaled magnitude data from various high and low frequency signal groups. These advancements showcase Girouard’s commitment to enhancing patient care through innovative technologies.
Career Highlights
Girouard has made significant strides in his career, particularly with his work at Brain Sentinel, Inc. and KCI Licensing, Inc. His efforts in these companies have focused on developing cutting-edge solutions aimed at improving the lives of those susceptible to seizure-related conditions.
Collaborations
Throughout his career, Girouard has collaborated with notable colleagues such as Jose E. Cavazos and Eric Woodson Barta. These collaborations have undoubtedly contributed to his innovative projects and the advancement of seizure detection technologies.
Conclusion
Michael Richard Girouard’s contributions to the field of medical technology, particularly in seizure detection and characterization, are commendable. His extensive patent portfolio reflects a strong dedication to innovation and improving patient outcomes in this critical area of healthcare.